Cargando…
Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics
Background: Severe mental illnesses are associated with increased risks for metabolic syndrome (MetS) and other medical disorders, often with unfavorable outcomes. MetS may be more likely with schizoaffective disorder (SzAff) than schizophrenia (Sz). MetS is associated with long-term antipsychotic d...
Autores principales: | Ventriglio, Antonio, Baldessarini, Ross J., Vitrani, Giovanna, Bonfitto, Iris, Cecere, Angela Chiara, Rinaldi, Angelo, Petito, Annamaria, Bellomo, Antonello |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343459/ https://www.ncbi.nlm.nih.gov/pubmed/30700975 http://dx.doi.org/10.3389/fpsyt.2018.00744 |
Ejemplares similares
-
Use of Psychoeducation for Psychotic Disorder Patients Treated With Modern, Long-Acting, Injected Antipsychotics
por: Ventriglio, Antonio, et al.
Publicado: (2021) -
Maternal perinatal depression and child neurocognitive development: A relationship still to be clarified
por: Severo, Melania, et al.
Publicado: (2023) -
Suicide in the Early Stage of Schizophrenia
por: Ventriglio, Antonio, et al.
Publicado: (2016) -
Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN)
por: Ifteni, Petru, et al.
Publicado: (2021) -
Adderall-Induced Persistent Psychotic Disorder Managed With Long-Acting Injectable Haloperidol Decanoate
por: Desai, Saral, et al.
Publicado: (2022)